0.41 USD
▼+0.03-3.67%
盘后 0.41 -3.53%
2026-08-03
市值
$2.18M
市盈率
—
EPS
-19.96
股息率
—
52 周区间
0.16 – 18.25
成交量
2.28M
Beta
1.75
目标价
21.00
52W 低 0.1652W 高 18.25
价格走势
公司简介
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activ...